homeostasis/metabolism
• mice show a decrease of plasma c-peptide levels compared to NOD/ShiLtJ controls
|
• mice show an increase in incidence of spontaneous diabetes, with increased levels of blood glucose and an earlier onset of type I diabetes, compared to NOD/ShiLtJ controls
|
immune system
• isolated CD4 T cells costimulated with anti-CD3/CD28 show increased CD4 T cell proliferation without an impact on T cell apoptosis
|
• mice exhibit increased infiltration of lymphocytes in the salivary gland
• however, no evidence of inflammatory infiltration is seen in the colon, lung, kidney, liver or heart
|
• mice exhibit more islets with invasive insulitis at both early prediabetic stage (5-6 weeks) and advanced diabetic stage 12 (12-15 weeks) compared to control NOD/ShiLtJ mice
|
• mice exhibit splenomegaly, suggesting a more severe autoimmune response than in NOD/ShiLtJ controls
|
• although the proportions of CD4 T cells and CD8 T cells in the pancreatic lymph nodes are comparable to controls, mice exhibit a higher proportion of CD44hi CD62Llo effector and lower proportion of CD44lo CD62Lhi nave T cells in total CD4 T cells
|
• the frequency of CD4+/IFN-gamma+ (Th1) cells is much higher than in controls
|
• mice show a modest increase of CD4+/IL-4+ (Th2) cells, but without a perceptible change in CD4+/IL-17A+ (Th17) and CD4+/Foxp3+ (Treg) subsets compared to controls
|
• frequency of IFN-gamma+ cytotoxic CD8 T cells is higher than in controls
|
• isolated CD4 T cells costimulated with anti-CD3/CD28 show increased CD4 T cell proliferation without an impact on T cell apoptosis, and higher amounts of type I cytokine expression, including IFN-gamma, GM-CSF, and TNF-alpha
• isolated CD4 T cells produce higher IFN-gamma levels under non-polarized conditions
|
• mice exhibit pancreatic lymphadenopathy, suggesting a more severe autoimmune response than in NOD/ShiLtJ controls
|
digestive/alimentary system
• mice exhibit increased infiltration of lymphocytes in the salivary gland
• however, no evidence of inflammatory infiltration is seen in the colon, lung, kidney, liver or heart
|
endocrine/exocrine glands
• mice exhibit increased infiltration of lymphocytes in the salivary gland
• however, no evidence of inflammatory infiltration is seen in the colon, lung, kidney, liver or heart
|
• mice show numerous shrunk islets with a reduction of insulin-positive cells compared to controls which show more structured islets and insulin-secreting beta cells
|
• mice exhibit more islets with invasive insulitis at both early prediabetic stage (5-6 weeks) and advanced diabetic stage 12 (12-15 weeks) compared to control NOD/ShiLtJ mice
|
growth/size/body
• mice exhibit splenomegaly, suggesting a more severe autoimmune response than in NOD/ShiLtJ controls
|
hematopoietic system
• isolated CD4 T cells costimulated with anti-CD3/CD28 show increased CD4 T cell proliferation without an impact on T cell apoptosis
|
• mice exhibit splenomegaly, suggesting a more severe autoimmune response than in NOD/ShiLtJ controls
|
• although the proportions of CD4 T cells and CD8 T cells in the pancreatic lymph nodes are comparable to controls, mice exhibit a higher proportion of CD44hi CD62Llo effector and lower proportion of CD44lo CD62Lhi nave T cells in total CD4 T cells
|
• the frequency of CD4+/IFN-gamma+ (Th1) cells is much higher than in controls
|
• mice show a modest increase of CD4+/IL-4+ (Th2) cells, but without a perceptible change in CD4+/IL-17A+ (Th17) and CD4+/Foxp3+ (Treg) subsets compared to controls
|
• frequency of IFN-gamma+ cytotoxic CD8 T cells is higher than in controls
|
• isolated CD4 T cells costimulated with anti-CD3/CD28 show increased CD4 T cell proliferation without an impact on T cell apoptosis, and higher amounts of type I cytokine expression, including IFN-gamma, GM-CSF, and TNF-alpha
• isolated CD4 T cells produce higher IFN-gamma levels under non-polarized conditions
|
cellular
• isolated CD4 T cells costimulated with anti-CD3/CD28 show increased CD4 T cell proliferation without an impact on T cell apoptosis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
type 1 diabetes mellitus | DOID:9744 |
OMIM:222100 |
J:323838 |